UC SANTA BARBARA (US) — Scientists have discovered new information about what happens to brain cells that are destroyed in Alzheimer’s disease and related dementias.
For years researchers have known that a small peptide named amyloid beta can cause neuronal cell death and Alzheimer’s disease, although the mechanism for how it works has been poorly understood. Recently, genetic evidence has demonstrated that the ability of amyloid beta to kill neurons requires a protein called “tau”; however, what it does to tau has been enigmatic.
Under normal conditions, tau is found in the long axons of neurons that serve to connect neurons with their targets, often far from the cell body itself.
“We know amyloid beta is a bad guy,” says study leader Stuart Feinstein, professor of molecular, cellular and developmental biology at the University of California, Santa Barbara. “Amyloid beta causes disease; amyloid beta causes Alzheimer’s. The question is how does it do it?”
Most Alzheimer’s researchers would argue that amyloid beta causes tau to become abnormally and excessively phosphorylated, says Feinstein. This means that the tau proteins get inappropriately chemically modified with phosphate groups. “Many of our proteins get phosphorylated,” adds Feinstein. “It can be done properly or improperly.”
Feinstein’s research team wanted to determine the precise details of the presumed abnormal phosphorylation of tau in order to gain a better understanding of what goes wrong. “That would provide clues for drug companies; they would have a more precise target to work on,” says Feinstein. “The more precisely they understand the biochemistry of the target, the better attack a pharmaceutical company can make on a problem.”
The team’s initial hypothesis suggesting that amyloid beta leads to extensive abnormal tau phosphorylation turned out not to be true. “We all like to get a curve ball tossed our way once in a while, right?” says Feinstein. “You like to see something different and unexpected.”
They found that when they added amyloid beta to neuronal cells, the tau in those cells did not get massively phosphorylated, as predicted. Rather, the surprising observation was the complete fragmentation of tau within one to two hours of exposure of the cells to amyloid beta. Within 24 hours, the cells were dead.
The findings are reported in the Journal of Biological Chemistry.
Feinstein explains that tau has many jobs, but its best-understood job is to regulate the cellular cytoskeleton. Cells have a skeleton much like humans have a skeleton. The major difference is that human skeletons don’t change shape very abruptly, whereas a cell’s skeleton is constantly growing, shortening, and moving. It does this in order to help the cell perform many of its essential functions. The cytoskeleton is especially important to neurons because of their great length.
Feinstein argues that neurons die in Alzheimer’s disease because their cytoskeleton is not working properly.
“If you destroy tau, which is an important regulator of the microtubules, one could easily see how that could also cause cell death,” says Feinstein. “We know from cancer drugs that if you treat cells with drugs that disrupt the cytoskeleton, the cells die,” he said. “In my mind, the same thing could be happening here.”
The Feinstein lab is now at work on the implications of the experiments described in the article.
More news from UC Santa Barbara: www.ucsb.edu/news-topics